Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
14.42M | 12.31M | 8.70M | 6.55M | 7.82M | 11.49M | Gross Profit |
12.47M | 10.57M | 7.35M | 5.86M | 6.29M | 7.61M | EBIT |
445.00K | 412.00K | -261.00K | -532.00K | -153.00K | 145.00K | EBITDA |
602.17K | 643.00K | -38.00K | -305.00K | 69.00K | 238.00K | Net Income Common Stockholders |
378.50K | 309.00K | -415.00K | -642.00K | -362.00K | -39.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
765.00K | 765.00K | 50.00K | 459.00K | 367.00K | 432.00K | Total Assets |
5.21M | 5.21M | 4.13M | 4.26M | 3.82M | 4.96M | Total Debt |
439.00K | 439.00K | 1.46M | 1.70M | 1.07M | 1.07M | Net Debt |
-326.00K | -326.00K | 1.41M | 1.24M | 705.00K | 637.00K | Total Liabilities |
3.83M | 3.83M | 3.46M | 3.43M | 2.72M | 3.60M | Stockholders Equity |
1.38M | 1.38M | 670.00K | 836.00K | 1.11M | 1.34M |
Cash Flow | Free Cash Flow | ||||
1.44M | 1.67M | -98.00K | -501.00K | 450.00K | -212.00K | Operating Cash Flow |
1.47M | 1.69M | -33.00K | -446.00K | 515.00K | -182.00K | Investing Cash Flow |
-49.00K | -43.00K | -116.00K | -69.00K | -88.00K | -91.00K | Financing Cash Flow |
-1.11M | -954.00K | -260.00K | 607.00K | -492.00K | 21.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | £11.64B | 37.33 | 25.84% | 1.71% | 6.78% | 55.05% | |
63 Neutral | $4.27B | 11.40 | 5.38% | 214.63% | 4.11% | -8.98% | |
60 Neutral | £822.40M | 28.74 | 10.00% | 6.37% | -13.50% | -62.86% | |
55 Neutral | £154.06M | 29.69 | -3.96% | 10.35% | -16.16% | -145.46% | |
48 Neutral | £1.74M | 7.84 | -11.91% | ― | -11.27% | -150.00% | |
46 Neutral | £12.11M | ― | -34.21% | 4.00% | -1.64% | -255.16% |
Norman Broadbent announced the posting of its 2024 Annual Report and Accounts, along with a notice for its upcoming Annual General Meeting (AGM) scheduled for May 22, 2025. A significant proposal to be discussed at the AGM is the consolidation and sub-division of the company’s share capital, which aims to streamline its share structure by converting 70 existing shares into two new ordinary shares and 150 deferred shares. This move is expected to optimize the company’s capital structure and potentially enhance shareholder value.
Norman Broadbent reported its best-ever quarter in Q1 2025, with net fee income increasing by 40% compared to Q1 2024, despite challenging market conditions. The company achieved its second-best annual performance in over a decade for FY 2024, reflecting a successful transformation and growth trajectory. With a strong start to 2025 and a growing book of contracted revenue, Norman Broadbent is well-positioned to navigate the unpredictable labor market and capitalize on future opportunities, aiming for sustainable growth and a medium-term EBITDA target of £1.25 million.
Norman Broadbent, a leading executive search and interim management firm, will release its audited final results for the year ending 31 December 2024 on 2 April 2025. The announcement will be accompanied by a virtual presentation and Q&A session hosted by CEO Kevin Davidson and CFO Mehr Malik, providing insights into the company’s performance and strategic direction, which could impact its market positioning and stakeholder engagement.